Publication
Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease
Downloadable Content
- Persistent URL
- Last modified
- 05/15/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2014-04-01
- Publisher
- Elsevier Masson
- Publication Version
- Copyright Statement
- © 2014 Elsevier B.V. All rights reserved.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 0166-3542
- Volume
- 104
- Issue
- 1
- Start Page
- 1
- End Page
- 6
- Grant/Funding Information
- This work was supported by NIH/NIAID grants AI105170 (S.M.K.); AI093772 (S.M.K.); AI087782 (S.M.K.); 1R01AI087798 (MLM); and 1U19AI095227 (MLM).
- The histology core facility in the Center for Inflammation, Immunity, & Infection was supported by Georgia Research Alliance.
- Abstract
- Maternal immunization of mice with formalin inactivated respiratory syncytial virus (FI-RSV) resulted in the passive transfer of RSV antibodies but not cellular components to the offspring. The offspring born to FI-RSV immunized mothers showed serum RSV neutralizing activity, effectively controlled lung viral loads without vaccine-enhanced disease, did not induce pulmonary eosinophilia, and cytokine producing cells after live RSV infection. Therefore, this study provides evidence that maternal immunization provides an in vivo model in investigating the roles of antibodies independent of cellular components.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Immunology
- Biology, Virology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - tw9p9.pdf | Primary Content | 2025-04-03 | Public | Download |